Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis

NCT00355901 is registered in ClinicalTrials.gov with PDL BioPharma, Inc. as lead sponsor.

NCT NCT00355901
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00355901 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Follow-up Study for Subjects Receiving Salvage Therapy After Previous Treatment in a Visilizumab Study for Intravenous Steroid-Refractory Ulcerative Colitis
Lead sponsor
PDL BioPharma, Inc.
Phase
Observational
Overall status
Terminated
Start date
September 30, 2006
Completion date
November 30, 2012
Enrollment
300 (estimated)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis